Related Articles

• Capecitabine‑induced hand‑foot syndrome does not emerge in the complex regional pain syndrome‑affected limb: A case report
• A new receptor tyrosine kinase inhibitor, icotinib, for patients with lung adenocarcinoma cancer without indication for chemotherapy
• Quick regression of brain metastases from lung adenocarcinoma with epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A case report and literature review
• Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand‑foot syndrome: A meta‑analysis
• Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines